Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to Exel Composites Plc’s Annual General Meeting 2022

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      15 FEBRUARY 2022 at 09:15 EETNotice is given to the shareholders of Exel Composites Plc to the Annual General Meeting of Shareholders to be held on Friday 25 March 2022 at 09:30 EET in Exel Composites’ premises at Mäkituvantie 5, 01510 Vantaa, Finland. Shareholders of the company may participate in the meeting and exercise their shareholders’ rights only through a proxy representative and by submitting counterproposals and questions in advance. Proxy representatives must see to the voting in advance on behalf of shareholders. Instructions

Merger plan signed with Lundin Energy

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange notice published by Aker BP ASA (“Aker BP”) on 21 December 2021 whereby it announced that Aker BP and Lundin Energy AB (“Lundin Energy”) had entered into a transaction agreement pursuant to which Aker BP and

New framework agreement for automation solutions in life science

Semcon has signed a new framework agreement as supplier to Graniten. The agreement, which runs indefinitely, covers services in robot programming, electrical design, mechanical design and validation.Graniten is a global product supplier in pharmaceutical and healthcare automation and offers products ranging from custom innovations to full-scale production equipment. The company is based on business and technological innovation and currently collaborates with a number of major partners within the pharmaceutical industry and lab automation. “This is a very interesting collaboration for us

Kemira Oyj: Announcement of manager’s transaction; President and CEO Jari Rosendal has purchased 5,000 Kemira shares

Kemira Oyj, Managers' transactions, February 15, 2022 at 9.05 am (EET)Kemira Oyj: Announcement of manager’s transaction; President and CEO Jari Rosendal has purchased 5,000 Kemira shares Kemira has received a notification from Jari Rosendal, President and CEO, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation.Detailed information about the transaction is given below.Person subject to the notification requirement:Name: Rosendal, JariPosition: Chief Executive OfficerIssuer: KEMIRA LEI: 74370031Y7RK5H88CQ48Notification type:

Lynparza combo delays progression risk in prostate

15 February 2022 07:00 GMT Lynparza plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic castration-resistant prostate cancer Combination was well tolerated and allowed patients to maintain their quality of life vs. patients treated with abiraterone alone PROpel Phase III trial results show clinically meaningful benefit in patients irrespective of homologous recombination repair gene mutations Positive results from the PROpel Phase III trial showed AstraZeneca and MSD's Lynparza (olaparib) in combination with abiraterone

Axolot Solutions Holding AB (publ) - Year-end report January-December 2021

Focus on cost efficient, sustainable holistic solutions, handling a larger flow range.Summary of the fourth quarter 2021 Financially · Net sales amounted to 586 tSEK (1 318 tSEK for the corresponding quarter in 2020), which refers to customer trial activities and studies. In the comparison period 2020, one AxoPur® system was sold. · Other revenues were 22 tSEK (286), which relates to public research grants and project support. · Earnings before interest and tax became -4 822 tSEK (-3 953). · Net earnings per share amounted to -0,09 SEK (-0,15). · Liquid funds were 12 868

Notice of 2021 Full Year Results

15 February 2022 Gulf Keystone Petroleum Ltd. (LSE: GKP) ("Gulf Keystone", "GKP" or "the Company") Notice of 2021 Full Year Results Gulf Keystone confirms that the Company's results for the year ended 31 December 2021 will be announced on Wednesday 30 March 2022. The management team will host a presentation for analysts and investors via live audio webcast which will be available on the Company's website. Enquiries: Gulf Keystone: +44 (0) 20 7514 1400  Aaron Clark, Head of Investor Relations aclark@gulfkeystone.com Celicourt Communications:

Aiforia signs agreement with South Korean biotech company to augment its novel drug discovery platform with AI

Aiforia and Genuv will collaborate to to integrate Aiforia’s deep learning AI into Genuv’s ATRIVIEW® discovery platform for neurodegenerative diseases.The two companies announced an agreement to add Aiforia’s artificial intelligence technology to Genuv’s ATRIVIEW® proprietary drug discovery platform, used to screen both existing drugs and new substances for neuroprotective and neuroregenerative effects. ATRIVIEW® was used to discover Genuv’s leading drug candidate, SNR1611, which has shown the ability to restore CNS function in preclinical models of amyotrophic lateral sclerosis (ALS) and

Exel Composites' Financial Statements Release Q1-Q4 2021: Revenue increased significantly, profitability declined

EXEL COMPOSITES PLC    FINANCIAL STATEMENTS RELEASE    15 FEBRUARY 2022 at 09:00 EETQ4 2021 in brief  · Order intake decreased by 8.8% to EUR 30.5 million (Q4 2020: 33.4).  · Revenue increased by 32.7% to EUR 36.5 million (27.5).  · Operating profit decreased to EUR 0.6 million (2.7), which is 1.8% of revenue (9.9). · Adjusted operating profit decreased to EUR 1.0 million (2.7), which is 2.8% of revenue (9.9).  · Earnings per share amounted to EUR 0.04 (0.09). Q1-Q4 2021 in brief  · Order intake increased by 21.8% to EUR 140.6 million (Q1-Q4 2020: 115.4).  ·

Entrepreneurs Carl Douglas and Anders Böös, together with Johanna Mattsson, want to give the world the cleanest filtered drinking water using Swedish Nordaq’s technology

Byline: Zap PR  Nordaq is a premium water that delivers the purest filtered water to 0.3 microns, which no other global water company is currently able to offer.   Nordaq started as a sustainability project to find a way to be able to drink the same water wherever you are in the world, and thus to offer a premium bottled water that tastes pure, without any transportation.   Transporting water over water is one of the most illogical things we can do because we automatically shrink our own source and make it harder to get clean water because we pollute the soil.

Sivers Semiconductors AB (publ), Year-End Report January – December 2021

Fourth quarter 2021 · Revenue amounted to SEK 23.390 M (29.707), a decrease of 21% · Profit before depreciation and amortization (EBITDA) amounted to SEK -23.422 M (3.108) · Operating profit/loss (EBIT) for the quarter was SEK -33.223 M (-4.632) · Profit/loss after tax was SEK -25.108 M (-0.563) · Earnings per share before and after dilution was SEK -0.15 (0.00) · Equity per share amounted to SEK 4.57 (3.41) · Profit for the quarter was negatively affected by acquisition costs of SEK 4.186 M.January- December 2021: · Revenue amounted to SEK 90.652 M (96.170), a

Kemira Oyj: Announcement of manager’s transaction; Chairman of the Board Jari Paasikivi has purchased 16,000 Kemira shares

Kemira Oyj, Managers' transactions, February 15, 2022 at 9.00 am (EET)Kemira Oyj: Announcement of manager’s transaction; Chairman of the Board Jari Paasikivi has purchased 16,000 Kemira shares Kemira has received a notification from Jari Paasikivi, Chairman of the Board, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation.Detailed information about the transaction is given below.Person subject to the notification requirement:Name: Paasikivi, JariPosition: Chairman of the BoardIssuer: KEMIRALEI: 74370031Y7RK5H88CQ48Notification

Alligo Year-end Report 1 January–31 December 2021

The formerly-named Momentum Group has changed its name to Alligo and is traded since 15 December 2021 under the new short name ALLIGO B.Fourth quarter highlights ·Revenue increased by 10 per cent to MSEK 2,458 (2,237). ·EBITA increased by 54 per cent to MSEK 250 (162), corresponding to an EBITA margin of 10.2 per cent (7.2). ·Operating profit amounted to MSEK 194 (147) and the operating margin was 7.9 per cent (6.6). Items affecting comparability had an impact on profit of MSEK -40 (0) and relate to losses on divestment of operations of MSEK 37 and costs in connection

Stille Signs Exclusive Distribution Agreement for Surgical Instruments in US

Stille AB (publ) announces the appointment of Synovis Micro Companies Alliance, Inc,. as its exclusive distributor of surgical instruments in the United States.With over 20 years of experience in the market, Synovis Micro Companies Alliance, Inc, a Baxter-owned company, has successfully targeted surgical disciplines that require the finest surgical instrumentation, including the microsurgical, plastics and cardiovascular disciplines. As of January 1st, 2022, Synovis has been appointed the exclusive distributor of Stille’s surgical instruments in the United States. “This is a major step

Össur hf: Annual General Meeting 8 March 2022

Announcement no. 06/2022 15 February 2022 Annual General Meeting 8 March 2022 Össur hf.'s Annual General Meeting will be held on Tuesday 8 March 2022 at 16:00 GMT. The Board of Directors has decided to utilize the authorization in Article 17 of the Company’s Articles of Association to have the Annual General Meeting virtual. Enclosed is the convocation, which includes the proposed agenda for the Annual General Meeting and information on shareholders’ participation and registration, shareholders’ rights, voting and proxies, and other practical matters, as well as the proposed

Meaningful Travel – Help make Thailand greener

Tourism Authority of Thailand (TAT), Stockholm office, proudly announces a “Meaningful Travel concept” for visiting Thailand with good conscience. The campaign aims to support nature conservation and protect green spaces throughout Thailand. As Thailand has started to reopen and welcome international travellers, it is a start for a new chapter of the Thai tourism for the sustainable and responsible tourism . The commitment of joining force between the private sector in travel and hospitality-related services together with the Tourism Authority of Thailand (TAT) in our effort to

Scout Gaming Group becomes new Pariplay Fusion™ partner

New partnership to bring unique fantasy sports vertical to platform offeringStockholm, 15[th] February 2022 – Scout Gaming Group is a new studio partner at Aspire Global’s Pariplay Ltd, the leading aggregator and content provider, strengthening the Fusion™ platform. Scout Gaming provides players with the ultimate fantasy sports experience and the partnership will see Pariplay enrich its offering with a unique and engaging product suite.   Scout Gaming offers a wide selection of game types and a full suite of sports with the ability to add other events upon request. The supplier also

Snow Acres and Wyld Networks collaborate to collect data from soil sensors in remote locations

Wyld Networks today announces a partnership with Snow Acres, a Canadian sustainable agricultural resource management company, to bring satellite-connected data to Snow Acre’s remote soil moisture sensing technology.Irrigated cropland currently makes up an estimated 275 million hectares globally and this is estimated to continue to grow by 0.6% annually. As climatic conditions add stress to water resource management, measuring soil moisture accurately will become ever more important for farmers, agronomists and agronomy platforms. Farmers and growers looking to meet the significant

Elypta launches Multi-Cancer Early Detection screening study measuring metabolic GAGome levels in asymptomatic adults

Stockholm, Feb 15, 2022: Swedish molecular diagnostic company Elypta announces today the launch of clinical study LEVANTIS-0087A (LEV87A), intended to validate the diagnostic performance of GAGomes – the complete profile of human glycosaminoglycans – as metabolic biomarkers for Multi-Cancer Early Detection (MCED). The study aims to detect any-type cancer in adults who show no symptoms or have any recent history of cancer. The study builds upon proof-of-concept data shared at the American Society of Clinical Oncology (ASCO) conference in June 2021 which indicated that GAGomes could detect one

Year-end report 2021

A strong finish to an excellent year Quarter 4, 2021 · Incoming orders amounted to SEK 1,352m (918), equivalent to currency-neutral growth of 47.8 percent compared with the same period last year. Compared with the corresponding quarter in 2019, incoming orders increased currency-neutral by 23.5 percent. · Net sales amounted to SEK 1,152m (940), equivalent to currency-neutral growth of 22.7 percent compared with the same period last year. · Operating profit was SEK 126.1m (93.8), giving an operating margin of 11.0 percent (10.0). · Adjusted operating profit was SEK 126.9m (

Gaming Innovation Group reports Q4 2021

Gaming Innovation Group Inc. (GiG) reports Q4 2021 revenues* of €18.2 million and an EBITDA of €5.6 million.  “We have closed off 2021 with another strong quarter with revenues up 29% to an all-time high, and an EBITDA up 35% compared to the fourth quarter of 2020, and importantly we have laid a truly exciting and expansive structure in place to further accelerate our global ambitions via the acquisition of SportnCo.”, says Richard Brown, CEO of GiG.  Financial Highlights · Revenues* in Q4 2021 were €18.2m (14.1), an increase of 29% YoY, all organic  · EBITDA was €5.6m (4.1),

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 February 2022 at 9.00 EETDuring the 1 January 2022 – 31 January 2022 conversion period there were five conversions and a total of 1,272 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 February 2022, and trading in the new R shares will start on 16 February 2022.Breakdown of shares after conversion:  A shares 176,242,072R shares 612,377,915Total 788,619,987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237,479,863.

FlexQube Reports Fourth Quarter and Full Year 2021 Results

FOURTH QUARTER 2021 · Order intake increased by 159.1 percent to 52.3 MSEK (20.2). Adjusted for foreign exchange rate effects between the comparison periods, orders received increased by 155.3 percent. · Net sales increased by 98.6 percent to 47,4 MSEK (23.9). Adjusted for foreign exchange rate effects between the comparison periods, net sales increased by 96.0 percent. · Operating profit before depreciation (EBITDA) amounted to -2.8 MSEK (-3.1) or -1.5 MSEK excluding inventory adjustments not related to the quarter and operating profit before financial items (EBIT) amounted to -

OncoZenge initiates toxicity study and announces modification to the clinical plan

OncoZenge AB (OMX: ONCOZ) has today commenced dosing in a toxicity study for its product candidate BupiZenge[®]. The study design is based on an advisory meeting with the Swedish Medical Agency and aims to document the safety of repeated oral topical administration of bupivacaine.Bupivacaine, which is the active pharmaceutical ingredient in BupiZenge[®], is the most widely used anesthetic for epidural anesthesia during childbirth, as well as for post-operative pain treatment. The compound and its safety profile has been extensively studied since it was first discovered more than sixty years

There are no items matching the current filter
There are no more items matching the current filter
Back to top